A detailed history of Baillie Gifford & CO transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 234,889 shares of TMDX stock, worth $19 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
234,889
Previous 257,466 8.77%
Holding current value
$19 Million
Previous $38.8 Million 4.9%
% of portfolio
0.03%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$135.68 - $176.11 $3.06 Million - $3.98 Million
-22,577 Reduced 8.77%
234,889 $36.9 Million
Q2 2024

Jul 25, 2024

SELL
$72.62 - $150.62 $3.32 Million - $6.88 Million
-45,696 Reduced 15.07%
257,466 $38.8 Million
Q1 2024

May 01, 2024

SELL
$70.86 - $89.93 $412,121 - $523,032
-5,816 Reduced 1.88%
303,162 $22.4 Million
Q4 2023

Jan 26, 2024

SELL
$36.74 - $81.08 $1.07 Million - $2.37 Million
-29,184 Reduced 8.63%
308,978 $24.4 Million
Q3 2023

Nov 13, 2023

BUY
$53.47 - $96.07 $5.17 Million - $9.28 Million
96,609 Added 39.99%
338,162 $18.5 Million
Q2 2023

Jul 28, 2023

SELL
$66.23 - $88.73 $756,280 - $1.01 Million
-11,419 Reduced 4.51%
241,553 $20.3 Million
Q1 2023

May 03, 2023

SELL
$53.63 - $82.33 $18,609 - $28,568
-347 Reduced 0.14%
252,972 $19.2 Million
Q4 2022

Jan 24, 2023

BUY
$39.08 - $64.29 $8.52 Million - $14 Million
218,048 Added 618.21%
253,319 $15.6 Million
Q3 2022

Oct 27, 2022

BUY
$31.56 - $55.75 $48,728 - $86,078
1,544 Added 4.58%
35,271 $1.47 Million
Q2 2022

Aug 08, 2022

SELL
$20.56 - $32.15 $29,853 - $46,681
-1,452 Reduced 4.13%
33,727 $1.06 Million
Q1 2022

May 05, 2022

BUY
$12.58 - $26.94 $78,096 - $167,243
6,208 Added 21.43%
35,179 $948,000
Q4 2021

Jan 20, 2022

BUY
$19.16 - $32.68 $531,670 - $906,837
27,749 Added 2270.79%
28,971 $555,000
Q3 2021

Oct 19, 2021

BUY
$25.92 - $34.51 $21,306 - $28,367
822 Added 205.5%
1,222 $40,000
Q1 2021

May 06, 2021

BUY
$17.75 - $47.82 $7,100 - $19,128
400 New
400 $17,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.58B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Baillie Gifford & CO Portfolio

Follow Baillie Gifford & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baillie Gifford & CO, based on Form 13F filings with the SEC.

News

Stay updated on Baillie Gifford & CO with notifications on news.